Wei Yuan, Wang Wen-Hui
Department of Pharmacology, New York Medical College, Valhalla, New York 10595, USA.
Am J Physiol Renal Physiol. 2002 Apr;282(4):F680-6. doi: 10.1152/ajprenal.00229.2001.
We have previously demonstrated that inhibiting protein tyrosine kinase (PTK) and stimulating protein kinase A (PKA) increase the activity of the small-conductance K (SK) channel in the cortical collecting duct (CCD) of rat kidneys (Cassola AC, Giebisch G, and Wang WH. Am J Physiol Renal Fluid Electrolyte Physiol 264: F502-F509, 1993; Wang WH, Lerea KM, Chan M, and Giebisch G. Am J Physiol Renal Physiol 278: F165-F171, 2000). In the present study, we used the patch-clamp technique to study the role of the cytoskeleton in mediating the effect of herbimycin A, an inhibitor of PTK, and vasopressin on the SK channels in the CCD. The addition of colchicine, an inhibitor of microtubule assembly, or taxol, an agent that blocks microtubule reconstruction, had no significant effect on channel activity. However, colchicine and taxol treatment completely abolished the stimulatory effect of herbimycin A on the SK channels in the CCD. Removal of the microtubule inhibitors restored the stimulatory effect of herbimycin A. In contrast, treatment of the tubules with either taxol or colchicine did not block the stimulatory effect of vasopressin on the SK channels. Moreover, the effect of herbimycin A on the SK channels was also absent in the CCDs treated with either cytochalasin D or phalloidin. In contrast, the stimulatory effect of vasopressin was still observed in the tubules treated with phalloidin. However, cytochalasin D treatment abolished the effect of vasopressin on the SK channels. Finally, the effects of vasopressin and herbimycin A are additive because inhibiting PTK can still increase the channel activity in CCD that has been challenged by vasopressin. We conclude that an intact cytoskeleton is required for the effect on the SK channels of inhibiting PTK and that the SK channels that are activated by inhibiting PTK were differently regulated from those stimulated by vasopressin.
我们之前已经证明,抑制蛋白酪氨酸激酶(PTK)并刺激蛋白激酶A(PKA)可增加大鼠肾脏皮质集合管(CCD)中小电导钾(SK)通道的活性(Cassola AC、Giebisch G和Wang WH。《美国生理学杂志:肾脏流体与电解质生理学》264:F502 - F509,1993;Wang WH、Lerea KM、Chan M和Giebisch G。《美国生理学杂志:肾脏生理学》278:F165 - F171,2000)。在本研究中,我们使用膜片钳技术来研究细胞骨架在介导PTK抑制剂除草霉素A和血管加压素对CCD中SK通道的作用中的作用。添加微管组装抑制剂秋水仙碱或阻断微管重建的药物紫杉醇对通道活性没有显著影响。然而,秋水仙碱和紫杉醇处理完全消除了除草霉素A对CCD中SK通道的刺激作用。去除微管抑制剂可恢复除草霉素A的刺激作用。相反,用紫杉醇或秋水仙碱处理肾小管并未阻断血管加压素对SK通道的刺激作用。此外,在用细胞松弛素D或鬼笔环肽处理的CCD中,除草霉素A对SK通道的作用也不存在。相反,在用鬼笔环肽处理的肾小管中仍观察到血管加压素的刺激作用。然而,细胞松弛素D处理消除了血管加压素对SK通道的作用。最后,血管加压素和除草霉素A的作用是相加的,因为抑制PTK仍可增加已受到血管加压素刺激的CCD中的通道活性。我们得出结论,抑制PTK对SK通道产生作用需要完整的细胞骨架,并且抑制PTK激活的SK通道与血管加压素刺激的SK通道的调节方式不同。